Cargando…
MicroRNA-182 targets protein phosphatase 1 regulatory inhibitor subunit 1C in glioblastoma
Glioblastoma (GBM) is an incurable cancer, with mean post-diagnosis survival time of 14-16 months. Metagenomic analysis by The Cancer Genome Atlas (TCGA) program has identified microRNA-182-5p (miR-182-5p or miR-182) as the only miRNA associated with favorable disease prognosis and temozolomide (TMZ...
Autores principales: | Liu, Liqiang, Zhang, Xiaowei, Nan, Chengrui, Zhao, Zongmao, Ma, Shucheng, Li, Wenhua, Hu, Hongchao, Liang, Zhaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777723/ https://www.ncbi.nlm.nih.gov/pubmed/29383111 http://dx.doi.org/10.18632/oncotarget.21309 |
Ejemplares similares
-
Expression and regulatory effects of microRNA-182 in osteosarcoma cells: A pilot study
por: BIAN, DONG-LIN, et al.
Publicado: (2016) -
Bone protection by inhibition of microRNA-182
por: Inoue, Kazuki, et al.
Publicado: (2018) -
The microRNA cluster miR-183/96/182 contributes to long-term memory in a protein phosphatase 1-dependent manner
por: Woldemichael, Bisrat T., et al.
Publicado: (2016) -
Down-regulation of microRNA-182 and microRNA-183 predicts progression of osteosarcoma
por: Golbakhsh, Mohammad Reza, et al.
Publicado: (2016) -
Mouse Rif1 is a regulatory subunit of protein phosphatase 1 (PP1)
por: Sukackaite, Rasa, et al.
Publicado: (2017)